These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3535016)

  • 21. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.
    Marshall BJ; Goodwin CS; Warren JR; Murray R; Blincow ED; Blackbourn SJ; Phillips M; Waters TE; Sanderson CR
    Lancet; 1988 Dec 24-31; 2(8626-8627):1437-42. PubMed ID: 2904568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological properties of colloidal bismuth subcitrate (CBS, DE-NOL).
    Wieriks J; Hespe W; Jaitly KD; Koekkoek PH; Lavy U
    Scand J Gastroenterol Suppl; 1982; 80():11-6. PubMed ID: 6962539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity of Campylobacter pylori to colloidal bismuth subcitrate.
    Goodwin CS; Bell B; McCullough C; Turner M
    J Clin Pathol; 1989 Feb; 42(2):216-7. PubMed ID: 2921366
    [No Abstract]   [Full Text] [Related]  

  • 24. The subcellular localisation and the time course of bismuth in the gastric mucosa of rats after short-term administration of colloidal bismuth subcitrate.
    Ismail NM; Mustapha MS; Megat R
    Ann Acad Med Singap; 1997 Nov; 26(6):754-7. PubMed ID: 9522974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.
    O'Riordan T; Mathai E; Tobin E; McKenna D; Keane C; Sweeney E; O'Morain C
    Gut; 1990 Sep; 31(9):999-1002. PubMed ID: 2210469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colloidal bismuth subcitrate causes sustained release of gastric mucosal prostaglandin E2.
    Mertz-Nielsen A; Steenberg P; Neumark T; Bukhave K; Rask-Madsen J
    Aliment Pharmacol Ther; 1991 Apr; 5(2):127-33. PubMed ID: 1888815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colloidal bismuth in the treatment of duodenal ulceration: the benefit for the patient.
    Miller JP
    Scand J Gastroenterol Suppl; 1989; 157():16-20; discussion 21-2. PubMed ID: 2568684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the mechanism of action of colloidal bismuth subcitrate. II. Interaction with pepsin.
    Beil W; Bierbaum S; Sewing KF
    Pharmacology; 1993 Aug; 47(2):141-4. PubMed ID: 8356103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of colloidal bismuth subcitrate on age related gastric lesions in the rat.
    Hinsull SM
    Gut; 1991 Apr; 32(4):355-60. PubMed ID: 2026333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colloidal bismuth subcitrate-induced changes on gastric mucosal hemodynamics in the rat: gastric mucosal blood flow after CBS treatment.
    Eleftheriadis E; Kotzampassi K; Tzartinoglou E; Salem A; Aletras H
    Gastroenterol Jpn; 1991 Jun; 26(3):283-6. PubMed ID: 1889688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Protective effect of colloidal bismuth subcitrate on gastric mucosal lesion induced by aspirin].
    Chen SP; Chen J; Wen SH
    Zhonghua Nei Ke Za Zhi; 1990 May; 29(5):293-5, 318. PubMed ID: 2242692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrocytoprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins.
    Konturek SJ; Radecki T; Piastucki I; Brzozowski T; Drozdowicz D
    Gut; 1987 Feb; 28(2):201-5. PubMed ID: 3470240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol).
    Morris A; Brown P; Ali MR; Lane M; Palmer R
    N Z Med J; 1988 Oct; 101(856 Pt 1):651-4. PubMed ID: 3054641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study.
    Kang JY; Tay HH; Wee A; Guan R; Math MV; Yap I
    Gut; 1990 Apr; 31(4):476-80. PubMed ID: 2186982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate.
    Loffeld RJ; Potters HV; Stobberingh E; Flendrig JA; van Spreeuwel JP; Arends JW
    Gut; 1989 Sep; 30(9):1206-12. PubMed ID: 2680795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal growth factor (EGF) in the gastroprotective and ulcer healing actions of colloidal bismuth subcitrate (De-Nol) in rats.
    Konturek SJ; Dembinski A; Warzecha Z; Bielanski W; Brzozowski T; Drozdowicz D
    Gut; 1988 Jul; 29(7):894-902. PubMed ID: 3260885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Morphology of the gastric mucosa in patients with duodenal ulcer treated with bismuth-containing drugs].
    Mach T
    Folia Med Cracov; 1995; 36(1-4):53-75. PubMed ID: 8834668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uptake and subcellular localisation of bismuth in the gastrointestinal mucosa of rats after short term administration of colloidal bismuth subcitrate.
    Stiel D; Murray DJ; Peters TJ
    Gut; 1985 Apr; 26(4):364-8. PubMed ID: 3979909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection against chemically-induced oxidative gastrointestinal tissue injury in rats by bismuth salts.
    Bagchi D; Carryl OR; Tran MX; Bagchi M; Vuchetich PJ; Krohn RL; Ray SD; Mitra S; Stohs SJ
    Dig Dis Sci; 1997 Sep; 42(9):1890-900. PubMed ID: 9331152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.